Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?Positive | ||
Negative | ||
Uncertain | ||
Constraining | ||
Legalese | ||
Litigous | ||
Readability |
H.S. sophomore Avg
|
New words:
accuracy, Adelphi, adjudication, adult, allegedly, anaphylactic, Ardea, Bachelor, Besse, biennial, Biomanufacturing, Biotech, box, boxed, breadth, broaden, Brooklyn, built, burdensome, call, Centocor, conversion, dedication, defective, degrading, description, disadvantage, disaggregate, drawn, EMA, encompassing, entirety, exact, exam, exempt, exemption, explaining, expressly, FairValue, feedback, Ferrari, filtration, flexibility, foregoing, forfeiture, formulary, fractional, harbor, HHS, hotline, hour, House, identification, ImClone, immigration, impede, imprisonment, incremental, Indenture, inexpensive, inflated, inflation, inhaled, insert, instability, interchangeable, John, Johnson, Lawrence, leveraged, Lou, MAA, mature, maturity, McKessson, memorandum, MMA, narrowly, needy, Nephrology, network, NOL, nonrecurring, nurse, nursing, Nutrition, oncology, Ortho, Oxford, permissible, persuasive, pharmacovigilance, Pharmacy, pill, pose, PPACA, prominent, proper, purified, qualification, rank, rare, reluctant, resubmitted, retroactive, root, scrutiny, semiannually, sham, shift, Similarly, sinking, sterile, sterilization, sterilized, subordinated, Sunshine, Supplementary, terrorism, underestimated, undergo, unpaid, unrest, unsecured, untreated, VA, viable, vial, visit, vulnerability, wholly, withdrawn, wrongfully
Removed:
Acacia, acknowledgement, appealed, Asia, Biopharma, BOA, Bulletin, carryback, cautionary, CFO, Citizen, classification, conclusion, Counter, daily, developmental, display, displayed, DMF, EMEA, enforcing, enterprise, exit, expanded, fluctuate, fluctuated, Frameworkissued, geriatric, Ingleby, inInternal, JV, manage, Marco, Neurotech, Officersin, overpayment, page, partnership, permitting, petition, poorly, precipitate, prepare, presently, reconsideration, recoverable, renew, sixty, soluble, unqualified, urine, weighted, wide
Filing tables
Filing exhibits
- 10-K Annual report
- 10.42 Employment Agreement
- 21.1 Subsidiaries of the Company
- 23.1 Consent of Mcgladrey & Pullen, LLP
- 31.1 Certification of CEO Pursuant to Section 302
- 31.2 Certification of CFO Pursuant to Section 302
- 32.1 Certification of CEO Pursuant to Section 906
- 32.2 Certification of CFO Pursuant to Section 906
SVNT similar filings
Filing view
External links
Exhibit 23.1
Consent of Independent Registered Public Accounting Firm
To the Board of Directors and Stockholders
Savient Pharmaceuticals, Inc.
We consent to the incorporation by reference in Registration Statements on (i) Form S-3 (no. 333-146257 and 333-171961) and (ii) Form S-8 (no. 333-36121, 333-33073, 333-33075, 333-64541, 333-87344 and 333-127068) filed by Savient Pharmaceuticals, Inc. of our Report dated March 1, 2011, relating to our audits of the consolidated financial statements, the financial statement schedule and internal control over financial reporting, included in this Annual Report on Form 10-K of Savient Pharmaceuticals, Inc. for the year ended December 31, 2010.
/s/ McGladrey & Pullen, LLP
New York, NY
March 1, 2011